The Therapeutic Data Commons (TDC) is a widely used resource for advancing the understanding of small-molecule drug development, with benchmark datasets sourced from the ChEMBL database and MoleculeNet benchmarks. In our experimental setup, we compared our model to the benchmark models on twentytwo ADMET datasets defined in "TDC ADMET Benchmark Group". This benchmark group contains six absorption endpoints, three distribution endpoints, six metabolism endpoints, three excretion endpoints, and four toxicity endpoints, with dataset size ranging from 573 to 13130 molecules. The twenty-two datasets cover the endpoints commonly used in pharmaceutical research, such as various CYP enzyme-related metabolism, half-life, clearance, and off-target effects.